KimberlySharonColeMD

PubMed

• 5 citations
  Deep learning generates synthetic cancer histology for explainability and education.
  James M Dolezal, Rachelle Wolk, Hanna M Hieromnimon, Frederick M Howard, Andrew Srisuwananukorn, Dmitry Karpeyev, Siddhi Ramesh, Sara Kochanny, Jung Woo Kwon, Meghana ...> ;NPJ Precision Oncology. 2023 May 29
• 6 citations
  Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer.
  Michal Marczyk, Tao Qing, Tess O'Meara, Vesal Yagahoobi, Vasiliki Pelekanou, Yalai Bai, Emily Reisenbichler, Kimberly S Cole, Xiaotong Li, Vignesh Gunasekharan, Eiman ...> ;NPJ Breast Cancer. 2022 Jul 22
• 6 citations
  Development of an immunohistochemical assay for Siglec-15.
  Saba Shafi, Thazin Nwe Aung, Charles Robbins, Jon Zugazagoitia, Ioannis Vathiotis, Niki Gavrielatou, Vesal Yaghoobi, Aileen Fernandez, Shuqiong Niu, Linda N Liu, Zacha...> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 2022 Jul 1
• 112 citations
  Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
  Elias, A., Christina Yau, Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze, Anne-Sophie Hamy, Marick Laé, Fabien Reyal, Gabe S Sonke, Tessa ...> ;The Lancet. Oncology. 2022 Jan 1
• 19 citations
  An Open Source, Automated Tumor Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
  Yalai Bai, Kimberly Cole, Sandra Martinez-Morilla, Fahad Shabbir Ahmed, Jon Zugazagoitia, Johan Staaf, Ana Bosch, Anna Ehinger, Emma Niméus, Johan Hartman, Balazs Acs,...> ;Clinical Cancer Research. 2021 Jun 4
• 22 citations
  Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers
  Tess O'Meara, Michal Marczyk, Tao Qing, Vesal Yaghoobi, Kim Blenman, Kimberly Cole, Vasiliki Pelekanou, David L. Rimm, Lajos Pusztai> ;JCO Precision Oncology. 2020 Jun 26
• 9 citations
  High frequency of p16 and SOX10 coexpression but not androgen receptor expression in triple-negative breast cancers
  Esther C. Yoon, Parker C. Wilson, Tao Zuo, Marguerite M. Pinto, Kimberly Cole, Malini Harigopal> ;Human Pathology. 2020 Jun 18
• 91 citations
  Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
  Emily Reisenbichler, Gang Han, Andrew M. Bellizzi, Veerle Bossuyt, Jane E. Brock, Kimberly Cole, Oluwole Fadare, Omar Hameed, Krisztina Z. Hanley, Beth T. Harrison, M....> ;Modern Pathology. 2020 Apr 16
• 18 citations
  Re-Evaluating E-Cadherin and β-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast Cancer.
  Kimberly Cole, Paige Kluz, Michael Jorgensen, Ryan Kolb, Andrew M. Bellizzi, Weizhou Zhang, Nicholas Borcherding> ;The American Journal of Pathology. 2018 Jun 4
• 78 citations
  IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
  Sarah Chiang, Britta Weigelt, Huei Chi Wen, Fresia Pareja, Ashwini Raghavendra, Luciano G. Martelotto, Kathleen A. Burke, Thais Basili, Anqi Li, Felipe C Geyer, Salvat...> ;Cancer Research. 2016 Dec 15
• 262 citations
  Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.
  Laura C. Collins, Kimberly Cole, Jonathan D. Marotti, Rong Hu, Stuart J. Schnitt, Rulla M. Tamimi> ;Modern Pathology. 2011 May 6
• 13 citations
  Biologic characteristics of premalignant breast disease.
  Kimberly Cole, Maria Dolores Tabernero, Karen S. Anderson> ;Cancer Biomarkers. 2011 Jan 1
• Join now to see all